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Background and aims: A popliteal block is effective in managing postoperative pain for foot 
surgery, but since the duration of analgesia is limited following a single-shot popliteal fossa 
block technique, methods to prolong effective postoperative analgesia are mandatory. The aim 
of this study was to assess the effect of adjuvants to ropivacaine on the duration of sensory and 
motor block.
Methods: In this double-blind randomized placebo-controlled study, we evaluated the  analgesic 
effect of clonidine or dexamethasone (DXM) when added to ropivacaine for hallux valgus  surgery. 
After obtaining institutional ethics research board approval and written informed consent, a total 
of 72 patients were randomly allocated. Fifty-seven of these patients were statistically analyzed. 
All patients received an ultrasound-guided single-shot popliteal fossa block with 30 mL of 
ropivacaine 0.75%, supplemented with saline, clonidine 100 µg, or DXM 5 mg. The primary 
end point was time to first pain sensation. Secondary end points were time to complete sensory 
and motor block regression.
Results: Compared to saline, duration to first pain sensation was prolonged by 9 hours 
(mean ± standard deviation: 31±9 hours) (42%) in the DXM group (P=0.024) and by 6 hours 
(28±10 hours) (27%) in the clonidine group (P=0.024). Compared to saline, DXM prolonged both 
complete sensory and motor blockade by 12 hours (25±7 hours) (46%) and 13 hours (36±6 hours) 
(55%), respectively, while clonidine prolonged complete sensory and motor blockade by 7 hours 
(30±7 hours) (27%) and 2 hours (22±5 hours) (10%), respectively. DXM prolonged sensory block 
regression time by 6 hours (21±7 hours) (41%) and clonidine by 2 hours (17±6 hours) (13%) 
compared to the control group (P=0.006). Similarly, DXM prolonged motor block regression 
by 7 hours (25±7 hours) (46%) and clonidine by 4 hours (21±4 hours) (19%) (P,0.0001).
Conclusion: Addition of DXM and clonidine to ropivacaine significantly prolonged the dura-
tion of postoperative sensory and motor block.
Keywords: popliteal block, hallux valgus, steroids, regional anesthesia, dexamethasone, 
clonidine
Introduction
Foot surgery is associated with severe pain that can extend significantly up to 48 hours 
and often requires large amounts of parenteral opioids.1,2 Sciatic nerve blockade reduces 
postoperative pain after major foot and ankle surgery with minimal side effects;3 how-
ever, the maximum duration of effective analgesia with long-acting local anesthetics 
after a single injection technique is only 8–24 hours.4 Therefore, perineural catheters 
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or local anesthetics in combination with adjuvants are often 
used in attempts to prolong the duration of a single-shot 
popliteal fossa block (SSPFB).5,6 Pharmacodynamics and 
pharmacokinetics of dexamethasone (DXM) and clonidine 
administered in regional nerve blocks are not yet fully under-
stood; however, quite some literature has been published 
concerning the prolonged effect of DXM and clonidine on 
block characteristics.
Clonidine is a frequently used additive to local 
 anesthetics7–9 and is used for neuraxial blocks (eg, caudal 
blocks in children10) and for peripheral nerve blocks.8 In par-
ticular, clonidine is known to prolong the duration of analge-
sia for brachial plexus and popliteal fossa blocks.11 However, 
some studies have reported no change in onset time or block 
duration.11–14 This lack of effect has been attributed to meth-
odological issues, eg, difficulties in data interpretation, lack 
of systematic controls, or to the specific intermediate- and 
short-acting local anesthetics that were studied.7 Additionally, 
many studies were performed prior to the widespread use of 
ultrasound-guided nerve blockade, which may have limited 
the accuracy of local anesthetic delivery.1–3,18
DXM has also shown some promise as an adjuvant that 
prolongs analgesia in brachial plexus blocks.15–18 Recently, 
Cummings et al5 reported prolonged analgesia when DXM 
was combined with a long-acting local anesthetic during 
interscalene block. Desmet et al and Cummings et al found 
that DXM (8 mg) as an adjuvant to ropivacaine or bupivacaine 
almost doubled block duration (up to 24 hours) when used 
as an additive for the interscalene block.5,18
In this double-blind randomized placebo-controlled 
study, we evaluated the addition of DXM or clonidine to 
an ultrasound-guided SSPFB with 30 mL of ropivacaine 
0.75%. The primary end point was time to first pain sensation 
visual analog scale ([VAS] score .3). We hypothesized that, 
compared to saline, DXM and clonidine prolong the time to 
first pain sensation.
Methods
Population and study design
This trial is registered at the Community Clinical Trial  System 
(EudraCT number: 2012-005573-31). Hospital  ethics com-
mittee approval (EC approval no 3734,  Commissie voor 
Medische Ethiek – Ziekenhuisnetwerk Antwerpen, December 
01, 2011) was received. All patients scheduled for elective foot 
surgery were screened. Exclusion criteria were refusal of the 
patient, protocol violations, Nonsteroidal anti-inflammatory 
drug (NSAID) intolerance, diabetic patients, allergy for local 
anesthetics, peripheral neuropathy, coagulation disorders, and 
patients with an impaired kidney function. Patients were asked 
to participate when no contraindications to study participation 
were identified. We asked 208 patients to give consent, but 
57 refused. A total of 72 patients were randomly allocated 
by a computer-generated model to one of three study groups 
(clonidine, DXM, or saline). Fifty-seven of these patients 
were statistically analyzed (Figure 1). An SSPFB sciatic nerve 
block was performed 60 minutes before surgery, and block 
onset times were recorded.
Procedure
Following establishment of intravenous (IV) access, an 
ultrasound-guided SSPFB was performed with the patient in 
the prone position using the posterior approach. The probe was 
placed in the popliteal fossa (short axis view of the nerves) 
to detect the popliteal artery and vein, and the biceps femoris 
muscle. The tibial nerve was identified usually lateral and more 
superficial to the popliteal artery. Following visualization of 
these structures, the probe was moved proximally to search for 
the bifurcation of the tibial nerve with the common peroneal 
nerve (4–10 cm proximal to the popliteal crease). Correct 
needle placement was confirmed using a nerve stimulator. 
Muscle twitches of the foot (plantar flexion, dorsiflexion or 
inversion of the ankle) evoked at a current of 0.5 mA served as 
an indicator of correct needle placement. When motor stimula-
tion was accomplished with #0.2 mA, or excessive resistance 
(pressure) to injection was felt, the needle was repositioned.
Ropivacaine was the local anesthetic of choice because 
of its favorable clinical19,20 and toxicity profile.21 Of the avail-
able concentrations, the 0.75% concentration was selected 
based on previous studies.19,22 Ropivacaine 0.75% (30 mL) 
was mixed with either 1 mL of saline (control group), 1 mL 
of DXM (5 mg), or 1 mL of clonidine (100 µg) according to 
randomized assignment that was prepared by the pharmacist 
and blinded to the blinded block performer. In total, 31 mL 
of local anesthetic mixture was injected.
“Donut” signs around the posterior tibial nerve and the 
common peroneal nerve indicated successful distribution 
of the study solution. Two anesthesiologists with extensive 
experience with the popliteal block performed all blocks.
A research assistant blinded to group allocation evaluated 
sensory and motor block every 5 minutes after injection until 
start of surgery and every 10 minutes after surgery until dis-
charge from the postanesthesia care unit. Sensory block was 
tested using a big toe pinprick and rated as 2= normal, 1= loss 
of sensation to pinprick, or 0= loss of sensation to light touch. 
Motor block was tested and rated as 2= normal movement, 
1= partial paresis of ankle or toe movement, or 0= absent 
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movement of the ankle and toes. Block success was 
defined as loss of sensation to pinprick (sensory score #1) 
45 minutes after injection of the local anesthetic mixture. 
Onset time was defined as the interval between the end of 
injection and loss of sensation to pinprick.23–28
All patients received general anesthesia induced with 
propofol (2.5 mg/kg) and sufentanil (0.1 µg/kg). A laryngeal 
mask airway was introduced following loss of conscious-
ness. Sevoflurane 1–1.5 minimum alveolar concentration 
(MAC) was administered through a laryngeal mask airway 
to maintain anesthesia. Inspiratory oxygen fraction was 40%. 
IV antibiotics were given before tourniquet insufflation. 
Standard anesthesia monitoring included pulse oximetry, 
capnography, noninvasive blood pressure, and a three-lead 
electrocardiogram. At the end of surgery, the tourniquet was 
deflated, and paracetamol 1 g was administered intravenously. 
Total tourniquet time was recorded from insufflation to defla-
tion. No skin or wound traction was applied at the end of 
surgery. The same surgeon performed all interventions.
Paracetamol 1 g was administered every 6 hours, and 
ketorolac (Taradyl®) 20 mg was administered every 8 hours 
for the first 24 hours. The leg was elevated, and early post-
operative mobilization was applied in the postanesthesia care 
unit and in the orthopedic ward.
After 24 hours, the analgesic regimen consisted of oral 
paracetamol 1 g qid and naproxen 550 mg bid. Patients who 
developed stomachache on the first postoperative day were 
excluded from the study because NSAIDs were stopped and 
tramadol sublingual was then given to manage pain.
A blinded study nurse performed all postoperative 
recordings. The primary outcome variable was the time 
between start of block and the f irst pain reported by 
the patient. Patient-reported pain scores were recorded 
using the VAS ranging from 0 (no pain) to 10 (worst pain 
imaginable). Patients were considered to have pain if the 
VAS score exceeded 3. Sensory and motor block regres-
sion times were self-reported by the patients at different 
times. They were asked to report VAS scores every 2 hours 
Flow diagram popliteal study
Enrollment
Allocation
Follow-up
Analysis
Analyzed (n=19) Analyzed (n=21)
Lost to follow-up: (n=1) psychic
decompensation (n=1) protocol
violation
Lost to follow-up: (n=2) protocol
violation
Discontinued intervention: (n=3)
NSAID intolerance on day 1
Discontinued intervention: (n=1)
NSAID intolerance on day 1
Assessed for eligibility (n=208)
Randomized (n=72)
Excluded (n=136)
Clonidine group
Control group
Dexamethasone group
Not meeting inclusion criteria (n=69)
Declined to participate (n=57)
Other reasons (n=10)
Received allocated intervention (n=24)
Excluded from analysis: (n=1)
too early discharge for
accurate data
Received allocated intervention (n=24)Did not receive allocated
intervention: (n=1 allergic
reaction before surgery)
Received allocated intervention
(n=23) Allocated to intervention (n=24)Allocated to intervention (n=24)
Allocated to intervention (n=24)
Lost to follow-up (n=1) block
failure, (n=2) protocol violation
Discontinued intervention:
(n=1) NSAID intolerance on day 1
Analyzed (n=18)
Excluded from analysis: (n=1) 
too early dischage for accurate
data
Figure 1 Flowchart of study patients.
Abbreviation: NSAID, nonsteroidal anti-inflammatory drug.
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until complete  sensory and motor block regression and to 
report supplementary scores when VAS scores exceeded 3 
out of 10. Complications such as sedation, nausea, vomiting, 
and itching were noted. Onset of sensory block regression 
was defined as the first moment any feeling returned in 
the toes, typically a tingling sensation; complete sensory 
regression was defined as the return of normal sensation to 
touch of the toes. Onset of motor block regression was the 
first time the patient was able to move toes, and complete 
motor regression was the subjective feeling of normal motor 
function of the lower leg. Patients were discharged after full 
recovery of sensory and motor block and with a VAS score 
of 3 or less. After discharge, they were asked to keep a diary 
of VAS scores for 2 days (at least four times a day).
Statistical analysis
Sample size calculations were performed, and 18 patients 
per group were deemed necessary to achieve a power of 
90% with a significance level of 0.05 to detect a difference 
of 6 hours in postoperative analgesia with estimated group 
standard deviations of 4.5 hours.18,29 A two-sided Student’s 
t-test was performed.
Block regression duration was modeled using Kaplan–
Meier curves, and a log-rank survival analysis was used to 
evaluate the differences among the study groups. Differences 
in age, tourniquet time, and motor and sensory block onset 
times were evaluated by Kruskal–Wallis analysis.
P-values ,0.05 were considered statistically significant. 
The Statistical Package for the Social Sciences (SPSS for 
Windows, version 17.0; SPSS Inc., Chicago, IL, USA) was 
used for these analyses.
Results
We screened 208 patients. Sixty-nine were excluded from 
participation and 57 refused to participate. Finally, 72 patients 
were enrolled, of whom 15 were excluded. In the control 
group, six people were excluded. One was excluded because 
of an allergic reaction to antibiotics prior to incision, one 
because of block failure, and one because of suspected 
NSAID intolerance on day 1 (gastric pain). In this group, 
there were two protocol violations on the surgical ward, and 
one patient was sent home early for adequate data  assessment. 
In the DXM group, there were five excluded patients. One 
patient turned out to be mentally instable for adequate data 
assessment. There was one protocol violation and three 
suspected NSAID intolerance. In the clonidine group, four 
people were excluded, two due to protocol violations, one 
with suspected NSAID intolerance, and one due to early 
discharge.
The groups did not differ in age, tourniquet time, and 
block onset times (sensory or motor) as shown by Kruskal–
Wallis analysis (Table 1).
After obtaining institutional ethics research board 
approval and written informed consent from eligible patients, 
57 American Society of Anesthesiologists classification 1 and 
2 patients were studied. All participants were female and the 
groups did not differ in other demographic characteristics. 
Onset of sensory and motor block did not differ among groups 
(Tables 2 and 3).
Compared to saline, duration to first pain sensation was 
prolonged by 9 hours (42%) with the addition of DXM 
(P=0.024) and by 6 hours (27%) with the addition of  clonidine 
(P=0.024). Compared to saline, DXM prolonged both com-
Table 1 Age, tourniquet time, and onset times of 57 subjects undergoing popliteal blockade
All Saline Dexamethasone Clonidine P-value
Age (years) 48±15 49±15 48±15 47±14 NS
Tourniquet time (minutes) 39±11 39±9 42±14 36±7 NS
Sensory onset time (minutes) 28±35 32±19 34±42 20±18 NS
Motor onset time (minutes) 33±28 33±20 43±58 24±18 NS
Note: Data is presented as mean ± standard deviation. 
Abbreviation: NS, nonsignificant.
Table 2 Primary and secondary end point results of 57 subjects undergoing popliteal blockade
Time to … Saline Dexamethasone Clonidine P-value
… First pain sensation (hours) 22±6 31±9 (+42%) 28±10 (+27%) 0.024
… First sensory regression (hours) 15±15 21±7 (+41%) 17±6 (+13%) 0.006
… First motor regression (hours) 17±4 25±7 (+46%) 21±4 (+19%) ,0.001
… Complete sensory regression (hours) 23±5 36±6 (+55%) 30±7 (+27%) ,0.001
… Complete motor regression (hours) 20±2 32±7 (+55%) 22±5 (+10%) ,0.001
Note: Data is presented as mean ± standard deviation.
Local and Regional Anesthesia 2016:9submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
20
Vermeylen et al
plete sensory and motor blockade by 12 and 13 hours (55%), 
respectively, while clonidine prolonged complete sensory 
and motor blockade by 7 hours (27%) and 2 hours (10%), 
respectively (Figure 1C and D).
DXM prolonged sensory block regression time by 
6 hours (41%) and clonidine by 2 hours (13%). Log-rank 
survival analysis showed that these findings are statistically 
significant (P=0.006). Similarly, DXM prolonged motor 
block regression by 7 hours (46%) and clonidine by 4 hours 
(19%) (P,0.0001). No significant side effects were recorded 
(Figure 2).
Discussion
Corticosteroids have a long history of use in neuraxial blocks 
and chronic pain treatment, for instance, in carpal tunnel 
syndrome, and they are acknowledged to be an effective 
and safe therapy.30 Desmet et al18 and Cummings et al5 have 
found no evidence that the off-label use of perineural DXM 
is harmful. When studying the effect of ropivacaine and 
different adjuvants on isolated sensory neuron cell bodies 
of rats, Williams et al31,32 found that, unlike ropivacaine, 
DXM did not increase cell death after 24 hours of exposure. 
Moreover, Ma et al33 reported a protective effect for DXM 
on bupivacaine-induced neuronal injury in rats. Thus, the 
short-term use of DXM appears to be safe34 and without risk 
for steroid-induced hyperglycemia.35
The perineural use of DXM has been widely published.31 
Both Cummings et al18 and Desmet et al5 found that when 
DXM was added to an interscalene block, DXM prolonged 
the interscalene nerve block nearly twofold. These authors 
used 8 and 10 mg DXM, while we used only 5 mg. This 
perhaps explains why in the present study the effect of 
DXM was less pronounced and a dose–response effect 
might occur. However, alternatively in the present study for 
the first time, DXM was added to a popliteal block, which 
also might explain the different results. Further difference 
between the present study and those of Cummings et al 
and Desmet et al is that we used ultrasound guidance to 
place the block.
Although the pharmacodynamics and pharmacokinet-
ics of DXM and clonidine administered in regional nerve 
blocks are not yet fully understood, there is increasing 
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Table 3 Pairwise analysis of block survival times
P-value Saline vs  
dexamethasone
Saline vs  
clonidine
Dexamethasone vs 
clonidine
Time to first pain sensation 0.004 0.089 0.684
First sensory regression 0.001 0.432 0.067
First motor regression ,0.001 0.022 0.006
Complete sensory regression ,0.001 0.005 0.245
Complete motor regression ,0.001 0.389 0.002
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evidence that DXM prolongs the duration of postoperative 
analgesia.5,18,36
Desmet et al18 also had an IV DXM group and concluded 
that IV DXM is as good as perineural DXM in terms of pain 
relief. It was previously already demonstrated that systemic 
steroids improve postoperative pain sensation and reduce post-
operative nausea and vomiting.37–39 Several hypotheses have 
been proposed to explain the analgesic effect of DXM. Steroids 
may induce vasoconstriction, leading to substantial reduction 
in the absorption of local anesthetic solution.15,40,41 Alterna-
tively, DXM might block nociceptive impulse transmission 
along unmyelinated C-fibers through its anti-inflammatory 
and/or immunosuppressive effect.5,42–44 After intracellular 
uptake, glucocorticoids activate cytoplasmatic receptors that 
bind to their response elements in DNA. This decreases the 
production of inflammatory proteins (eg, cyclooxygenase-2, 
inducible nitric oxide synthase, cytoplasmatic phospholipase 
A2, interleukins, and inflammatory chemokines) and increases 
the  production of anti- inflammatory proteins (lipocortin-1 
receptor antagonist).18,45
Although clonidine is the most frequently used  perineural 
additive to local anesthetics,46,47 its role as adjuvant in 
periphe ral nerve blocks remains controversial, and side 
effects seem to increase at doses above 150 µg.46 YaDeau et al7 
showed that a popliteal nerve block duration was prolonged 
when 100 µg of clonidine was added to bupivacaine. None-
theless, the peripheral analgesic effect of clonidine remains 
unclear, and further investigation examining the mechanisms 
of action is required.
The present study has significant limitations. Since we did 
not use IV patient-controlled analgesia morphine as rescue 
analgesia, we could not conclude that opioid sparing occurs 
with DXM or  clonidine. However, to our knowledge, this is 
the first study to look at not only the analgesic effect but also 
in combination with sensory and motor block characteristics. 
Furthermore, we used a relatively large amount of local anes-
thetic volume (30 mL). It can be argued that given the fact 
that ultrasound was used for block placement, lower volumes 
should have been injected. However, since previous studies 
used high volumes, we decided to use similar volumes in the 
present study. Further study is required to evaluate if DXM 
can effectively reduce the dose of local anesthetic without 
affecting the duration of analgesia.
Conclusion
Our results demonstrate that adjuvants with ropivacaine 
0.75% prolong the duration of an SSPFB. This is the first 
study to use a limited dose (5 mg) of DXM for SSPFB. 
Perineural clonidine (limited to 100 µg) also prolonged 
block duration but to a lesser extent than DXM. Future 
dose– response studies are needed to evaluate if the positive 
effects of DXM are also present in lower doses. Additionally, 
 neuronal toxicity of DXM and its effects on glucose meta-
bolism need further study. Furthermore, combining clonidine 
and DXM might produce additive or synergistic effects.
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